Sangamo Therapeutics
SGMO
#9332
Rank
C$0.13 B
Marketcap
C$0.37
Share price
7.94%
Change (1 day)
-60.76%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -C$0.16 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are C$32.87 Million. In 2024 the company made an earning of -C$0.14 Billion, an increase over its 2023 earnings that were of -C$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.16 Billion12.42%
2024 -C$0.14 Billion-17.27%
2023 -C$0.17 Billion-40.88%
2022 -C$0.28 Billion9.79%
2021 -C$0.26 Billion41.52%
2020 -C$0.18 Billion23.17%
2019 -C$0.15 Billion36.33%
2018 -C$0.11 Billion36.89%
2017 -C$78.29 Million-22.32%
2016 -C$0.11 Billion54.86%
2015 -C$65.09 Million75.62%
2014 -C$37.07 Million0.13%
2013 -C$37.02 Million
2011 -C$49.76 Million43.66%
2010 -C$34.64 Million28.52%
2009 -C$26.95 Million-23.55%
2008 -C$35.26 Million2.45%
2007 -C$34.41 Million19.5%
2006 -C$28.8 Million50.78%
2005 -C$19.1 Million75%
2004 -C$10.92 Million-33.25%
2003 -C$16.35 Million-62.27%
2002 -C$43.33 Million102.82%
2001 -C$21.37 Million23.21%
2000 -C$17.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.60 B-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.46 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.16 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-C$3.49 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.60 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.14 B-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$0.79 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.67 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA